This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhan, Y F Articles by Cheers, C Search for Related Content PubMed PubMed Citation Articles by Zhan, Y F Articles by Cheers, C

 Previous Article  |  Next Article 

Infect Immun. 1991 May; 59(5): 1790-1794

Prophylaxis or treatment of experimental brucellosis with interleukin-1.

Department of Microbiology, University of Melbourne, Parkville, Victoria, Australia.

ABSTRACT

Intravenously injected recombinant human interleukin-1 alpha (IL-1 alpha) given to mice 4 h before infection with Brucella abortus 19 depressed the growth of bacteria in the spleen and liver. However, the same dose (10(5) U) or a 10-fold higher dose was not able to decrease numbers of bacteria when given to chronically infected mice. IL-1 injected into normal mice induced a dramatic increase 2 h later in colony-stimulating activity in serum, measured by bone marrow proliferation, and in colony-stimulating factor 1, measured by radioimmunoassay. Colony-stimulating factor levels declined but remained higher than normal for at least 12 h. The early peak stimulation was not observed in chronically infected mice, but the more prolonged elevation was. As a result of IL-1 treatment, the number of colony-forming cells, especially in the spleen, was increased in normal and acutely or chronically infected mice. Myeloperoxidase staining of newly formed monocytes and polymorphonuclear cells in the spleen revealed an increase in the number of these cells in normal and acutely infected mice as a result of IL-1 treatment, but there was no increase in the already high numbers in chronically infected mice. The relationship between these observations and the basis of chronic infection are discussed.

This article has been cited by other articles:

• Jimenez de Bagues, M. P., Terraza, A., Gross, A., Dornand, J. (2004). Different Responses of Macrophages to Smooth and Rough Brucella spp.: Relationship to Virulence. Infect. Immun. 72: 2429-2433 [Abstract] [Full Text]  
• Ko, J., Splitter, G. A. (2003). Molecular Host-Pathogen Interaction in Brucellosis: Current Understanding and Future Approaches to Vaccine Development for Mice and Humans. Clin. Microbiol. Rev. 16: 65-78 [Abstract] [Full Text]  
• Gross, A., Spiesser, S., Terraza, A., Rouot, B., Caron, E., Dornand, J. (1998). Expression and Bactericidal Activity of Nitric Oxide Synthase in Brucella suis-Infected Murine Macrophages. Infect. Immun. 66: 1309-1316 [Abstract] [Full Text]  
• (1996). Grand Rounds--Hammersmith Hospital: A case of laboratory acquired brucellosis. BMJ 313: 1130-1132 [Full Text]